Cheungpasitporn Wisit, Thongprayoon Charat, Mao Michael A, Mao Shennen A, D'Costa Matthew R, Kittanamongkolchai Wonngarm, Kashani Kianoush B
Wisit Cheungpasitporn, Charat Thongprayoon, Michael A Mao, Shennen A Mao, Matthew R D'Costa, Wonngarm Kittanamongkolchai, Kianoush B Kashani, Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MI 55905, United States.
World J Transplant. 2017 Feb 24;7(1):81-87. doi: 10.5500/wjt.v7.i1.81.
To evaluate the incidence of contrast-induced acute kidney injury (CIAKI) in kidney transplant recipients.
A literature search was performed using MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews from the inception of the databases through July 2016. Studies assessing the incidence of CIAKI in kidney transplant recipients were included. We applied a random-effects model to estimate the incidence of CIAKI.
Six studies of 431 kidney transplant recipients were included in the analyses to assess the incidence of CIAKI in kidney transplant recipients. The estimated incidence of CIAKI and CIAKI-requiring dialysis were 9.6% (95%CI: 4.5%-16.3%) and 0.4% (95%CI: 0.0%-1.2%), respectively. A sensitivity analysis limited only to the studies that used low-osmolar or iso-osmolar contrast showed the estimated incidence of CIAKI was 8.0% (95%CI: 3.5%-14.2%). The estimated incidences of CIAKI in recipients who received contrast media with cardiac catheterization, other types of angiogram, and CT scan were 16.1% (95%CI: 6.6%-28.4%), 10.1% (95%CI: 4.2%-18.0%), and 6.1% (95%CI: 1.8%-12.4%), respectively. No graft losses were reported within 30 d post-contrast media administration. However, data on the effects of CIAKI on long-term graft function were limited.
The estimated incidence of CIAKI in kidney transplant recipients is 9.6%. The risk stratification should be considered based on allograft function, indication, and type of procedure.
评估肾移植受者中对比剂诱导的急性肾损伤(CIAKI)的发生率。
使用MEDLINE、EMBASE和Cochrane系统评价数据库,从各数据库建立至2016年7月进行文献检索。纳入评估肾移植受者中CIAKI发生率的研究。我们应用随机效应模型来估计CIAKI的发生率。
纳入六项研究共431例肾移植受者,以分析肾移植受者中CIAKI的发生率。CIAKI及需要透析的CIAKI的估计发生率分别为9.6%(95%CI:4.5%-16.3%)和0.4%(95%CI:0.0%-1.2%)。仅对使用低渗或等渗对比剂的研究进行的敏感性分析显示,CIAKI的估计发生率为8.0%(95%CI:3.5%-14.2%)。接受心脏导管插入术、其他类型血管造影和CT扫描时使用对比剂的受者中CIAKI的估计发生率分别为16.1%(95%CI:6.6%-28.4%)、10.1%(95%CI:4.2%-18.0%)和6.1%(95%CI:1.8%-12.4%)。对比剂给药后30天内未报告移植物丢失。然而,关于CIAKI对长期移植物功能影响的数据有限。
肾移植受者中CIAKI的估计发生率为9.6%。应根据移植肾功能、适应证和手术类型考虑风险分层。